Reference health

Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases

https://doi.org/10.14309/ajg.0000000000001619
CiteStamped reference-health badge
25/25 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 25 checked references that resolve
resolves10.1016/j.jcv.2020.104371
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis
resolves10.1016/j.cegh.2020.100694
Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
resolves10.1001/jamainternmed.2020.3539
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
resolves10.1056/NEJMoa2035389
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
resolves10.1056/NEJMoa2034201
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
resolves10.1056/NEJMoa2034577
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
resolves10.3390/v13050756
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
resolves10.1016/j.jhep.2021.04.020
Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
resolves10.1136/gutjnl-2021-324789
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
resolves10.1136/gutjnl-2021-324388
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
resolves10.1053/j.gastro.2021.05.044
Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
resolves10.1053/j.gastro.2021.06.016
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
resolves10.1038/ajg.2009.197
The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity
resolves10.1038/ajg.2009.523
Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease
resolves10.15585/mmwr.mm7018e1
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
resolves10.1101/2021.07.29.21261317
Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study
resolves10.1101/2021.08.03.21261496
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
resolves10.2139/ssrn.3902782
Comparison of Two Highly-Effective mRNA Vaccines for COVID-19 During Periods of Alpha and Delta Variant Prevalence
resolves10.1001/jama.2021.15125
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
resolves10.1101/2021.08.02.21261516
COVID19 vaccine type and humoral immune response in patients receiving dialysis
resolves10.1053/j.gastro.2021.08.014
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease
resolves10.1101/2021.07.19.452771
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
resolves10.1097/01.MIB.0000441348.32570.34
Validation of an Internet-Based Cohort of Inflammatory Bowel Disease (CCFA Partners)
resolves10.1101/2021.11.05.21265968
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort
resolves10.1586/erv.10.61
Methods to measure vaccine immunity
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.14309/ajg.0000000000001619"><img src="https://citestamp.com/citestamped/10.14309/ajg.0000000000001619/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.14309/ajg.0000000000001619/badge.svg)](https://citestamp.com/citestamped/10.14309/ajg.0000000000001619)